Lauren Scott, MD, PhD is an Assistant Professor of Family Medicine at the Boston University School of Medicine and a Physician in the Department of Family Medicine at South End Community Health Center. In 2016, Dr. Scott won the Resident Leadership Award from her alma mater McMaster University where she was previously the Chief Resident in 2014. She is licensed in both Ontario and Massachusetts and was a member of both the Canadian and American Medical Association.
- Boston University School of Medicine, MD
- University of British Columbia, PhD
- McMaster University, BSc
- Published on 12/5/2017
Temple JR, Choi HJ, Reuter T, Wolfe D, Taylor CA, Madigan S, Scott LE. Childhood Corporal Punishment and Future Perpetration of Physical Dating Violence. J Pediatr. 2018 Mar; 194:233-237. PMID: 29217100.
- Published on 2/1/2014
Telpoukhovskaia MA, Rodríguez-Rodríguez C, Cawthray JF, Scott LE, Page BD, Alí-Torres J, Sodupe M, Bailey GA, Patrick BO, Orvig C. 3-Hydroxy-4-pyridinone derivatives as metal ion and amyloid binding agents. Metallomics. 2014 Feb; 6(2):249-62. PMID: 23999879.
- Published on 12/22/2013
Telpoukhovskaia MA, Rodríguez-Rodríguez C, Scott LE, Page BD, Patrick BO, Orvig C. Synthesis, characterization, and cytotoxicity studies of Cu(II), Zn(II), and Fe(III) complexes of N-derivatized 3-hydroxy-4-pyridiones. J Inorg Biochem. 2014 Mar; 132:59-66. PMID: 24393377.
- Published on 1/1/2011
Scott LE, Telpoukhovskaia M, Rodríguez-Rodríguez C, Merkel M, Bowen ML, Page BDG, Green DE, Storr T, Thomas F, Allen DD, Lockman PR, Patrick BO, Adam MJ, Orvig C. N-Aryl-substituted 3-(ß-D-glucopyranosyloxy)-2-methyl-4(1H)-pyridinones as agents for Alzheimer's therapy. Chemical Science. 2011; 2:642-8.
- Published on 12/11/2009
Green DE, Bowen ML, Scott LE, Storr T, Merkel M, Böhmerle K, Thompson KH, Patrick BO, Schugar HJ, Orvig C. In vitro studies of 3-hydroxy-4-pyridinones and their glycosylated derivatives as potential agents for Alzheimer's disease. Dalton Trans. 2010 Feb 14; 39(6):1604-15. PMID: 20104324.
- Published on 10/1/2009
Scott LE, Orvig C. Medicinal inorganic chemistry approaches to passivation and removal of aberrant metal ions in disease. Chem Rev. 2009 Oct; 109(10):4885-910. PMID: 19637926.
- Published on 3/5/2009
Storr T, Scott LE, Bowen ML, Green DE, Thompson KH, Schugar HJ, Orvig C. Glycosylated tetrahydrosalens as multifunctional molecules for Alzheimer's therapy. Dalton Trans. 2009 Apr 28; (16):3034-43. PMID: 19352532.
- Published on 10/6/2008
Scott LE, Page BD, Patrick BO, Orvig C. Altering pyridinone N-substituents to optimise activity as potential prodrugs for Alzheimer's disease. Dalton Trans. 2008 Dec 07; (45):6364-7. PMID: 19002321.
- Published on 5/19/2007
Storr T, Merkel M, Song-Zhao GX, Scott LE, Green DE, Bowen ML, Thompson KH, Patrick BO, Schugar HJ, Orvig C. Synthesis, characterization, and metal coordinating ability of multifunctional carbohydrate-containing compounds for Alzheimer's therapy. J Am Chem Soc. 2007 Jun 13; 129(23):7453-63. PMID: 17511455.
- Published on 1/1/2007
Schugar H, Green DE, Bowen ML, Scott LE, Storr T, Böhmerle K, Thomas F, Allen DD, Lockman PR, Merkel M, Thompson KH, Orvig C. Combating Alzheimer's disease with multifunctional molecules designed for metal passivation. Angew Chem Int Ed Engl. 2007; 46(10):1716-8. PMID: 17397084.